Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes

Heba M Ismail

doi:10.1210/clinem/dgab442

Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes

J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4786-e4788. doi: 10.1210/clinem/dgab442.

Author

Heba M Ismail¹

Affiliation

¹ Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

No abstract available

Keywords: DDP-4 inhibitor; abnormal glucose tolerance; cystic fibrosis-related diabetes; glucagon; glucagon-like peptide1 (GLP-1); glucose-dependent insulinotropic polypeptide; incretin; insulin; sitagliptin.

Publication types

Editorial
Comment

MeSH terms

Cystic Fibrosis* / complications
Diabetes Mellitus*
Dipeptidyl-Peptidase IV Inhibitors*
Gastric Inhibitory Polypeptide
Humans
Sitagliptin Phosphate

Substances

Dipeptidyl-Peptidase IV Inhibitors
Gastric Inhibitory Polypeptide
Sitagliptin Phosphate